Skip to main content
Journal cover image

VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL

Publication ,  Conference
Peters, KB; Reardon, DA; Vredenburgh, JJ; Desjardins, A; Herndon, JE; Coan, A; McSherry, F; Lipp, E; Brickhouse, A; Massey, W; Friedman, HS
Published in: NEURO-ONCOLOGY
October 1, 2012

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2012

Volume

14

Start / End Page

81 / 81

Location

Washington, DC

Publisher

OXFORD UNIV PRESS INC

Conference Name

17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Reardon, D. A., Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Coan, A., … Friedman, H. S. (2012). VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. In NEURO-ONCOLOGY (Vol. 14, pp. 81–81). Washington, DC: OXFORD UNIV PRESS INC.
Peters, Katherine B., David A. Reardon, James J. Vredenburgh, Annick Desjardins, James E. Herndon, April Coan, Frances McSherry, et al. “VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL.” In NEURO-ONCOLOGY, 14:81–81. OXFORD UNIV PRESS INC, 2012.
Peters KB, Reardon DA, Vredenburgh JJ, Desjardins A, Herndon JE, Coan A, et al. VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Peters, Katherine B., et al. “VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL.” NEURO-ONCOLOGY, vol. 14, OXFORD UNIV PRESS INC, 2012, pp. 81–81.
Peters KB, Reardon DA, Vredenburgh JJ, Desjardins A, Herndon JE, Coan A, McSherry F, Lipp E, Brickhouse A, Massey W, Friedman HS. VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 81–81.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2012

Volume

14

Start / End Page

81 / 81

Location

Washington, DC

Publisher

OXFORD UNIV PRESS INC

Conference Name

17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences